CYTOF
Altamira Therapeutics Ltd

25,315
Mkt Cap
$553,800.00
Volume
16,659.00
52W High
$0.62
52W Low
$0.0501
PE Ratio
-0.08
CYTOF Fundamentals
Price
$0.0969
Prev Close
$0.093
Open
$0.093
50D MA
$0.0761
Beta
0.99
Avg. Volume
6,251.70
EPS (Annual)
-$2.99
P/B
0.14
Rev/Employee
$0.00
Loading...
Loading...
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
13

Frequently Asked Questions

What is Market Cap of Altamira Therapeutics Ltd?
What is the 52-week high for Altamira Therapeutics Ltd?
What is the 52-week low for Altamira Therapeutics Ltd?
What is Altamira Therapeutics Ltd stock price today?
What was Altamira Therapeutics Ltd stock price yesterday?
What is the PE ratio of Altamira Therapeutics Ltd?
What is the Price-to-Book ratio of Altamira Therapeutics Ltd?
What is the 50-day moving average of Altamira Therapeutics Ltd?
How many employess does Altamira Therapeutics Ltd has?

Latest CYTOF News

View
No CYTOF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.